Ouabain inhibitor rostafuroxin attenuates dextromethorphan-induced manic potential. 2021

Eun-Joo Shin, and Bao-Trong Nguyen, and Ji Hoon Jeong, and Bao-Chau Hoai Nguyen, and Ngoc Kim Cuong Tran, and Naveen Sharma, and Dae-Joong Kim, and Seung-Yeol Nah, and David Lichtstein, and Toshitaka Nabeshima, and Hyoung-Chun Kim
Neuropsychopharmacology and Toxicology Program, College of Pharmacy, Kangwon National University, Chunchon, 24341, Republic of Korea.

Dextromethorphan (DM) abuse produces mania-like symptoms in humans. ERK/Akt signaling activation involved in manic potential can be attenuated by the inhibition of ouabain-like cardiac steroids. In this study, increased phosphorylations of ERK/Akt and hyperlocomotion induced by DM (30 mg/kg, i.p./day × 7) were significantly protected by the ouabain inhibitor rostafuroxin (ROSTA), suggesting that DM induces the manic potential. ROSTA significantly attenuated DM-induced protein kinase C δ (PKCδ) phosphorylation, GluN2B (i.e., MDA receptor subunit) expression, and phospho-PKCδ/GluN2B interaction. DM instantly upregulated the nuclear factor erythroid-2-related factor 2 (Nrf2)-dependent system. However, DM reduced Nrf2 nuclear translocation, Nrf2 DNA binding activity, γ-glutamylcysteine mRNA expression, and subsequent GSH/GSSG level and enhanced oxidative parameters following 1-h of administration. ROSTA, PKCδ inhibitor rottlerin, and GluN2B inhibitor traxoprodil significantly attenuated DM-induced alterations in Nrf2-related redox parameters and locomotor activity induced by DM in wild-type mice. Importantly, in PKCδ knockout mice, DM failed to alter the above parameters. Further, ROSTA and traxoprodil also failed to enhance PKCδ depletion effect, suggesting that PKCδ is a critical target for the anti-manic potential of ROSTA or GluN2B antagonism. Our results suggest that ROSTA inhibits DM-induced manic potential by attenuating ERK/Akt activation, GluN2B/PKCδ signalings, and Nrf2-dependent system.

UI MeSH Term Description Entries
D008124 Locomotion Movement or the ability to move from one place or another. It can refer to humans, vertebrate or invertebrate animals, and microorganisms. Locomotor Activity,Activities, Locomotor,Activity, Locomotor,Locomotor Activities
D008297 Male Males
D010042 Ouabain A cardioactive glycoside consisting of rhamnose and ouabagenin, obtained from the seeds of Strophanthus gratus and other plants of the Apocynaceae; used like DIGITALIS. It is commonly used in cell biological studies as an inhibitor of the NA(+)-K(+)-EXCHANGING ATPASE. Acocantherin,G-Strophanthin,Acolongifloroside K,G Strophanthin
D003915 Dextromethorphan Methyl analog of DEXTRORPHAN that shows high affinity binding to several regions of the brain, including the medullary cough center. This compound is an NMDA receptor antagonist (RECEPTORS, N-METHYL-D-ASPARTATE) and acts as a non-competitive channel blocker. It is one of the widely used ANTITUSSIVES, and is also used to study the involvement of glutamate receptors in neurotoxicity. d-Methorphan,Delsym,Dextromethorphan Hydrobromide,Dextromethorphan Hydrobromide, (+-)-Isomer,Dextromethorphan Hydrobromide, Monohydrate,Dextromethorphan Hydrochloride,Dextromethorphan, (+-)-Isomer,Racemethorphan,Hydrobromide, Dextromethorphan,Hydrochloride, Dextromethorphan
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000732 Androstanols Androstanes and androstane derivatives which are substituted in any position with one or more hydroxyl groups. Hydroxyandrostanes
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001714 Bipolar Disorder A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence. Affective Psychosis, Bipolar,Bipolar Disorder Type 1,Bipolar Disorder Type 2,Bipolar Mood Disorder,Depression, Bipolar,Manic Depression,Manic Disorder,Manic-Depressive Psychosis,Psychosis, Manic-Depressive,Type 1 Bipolar Disorder,Type 2 Bipolar Disorder,Psychoses, Manic-Depressive,Bipolar Affective Psychosis,Bipolar Depression,Bipolar Disorders,Bipolar Mood Disorders,Depression, Manic,Depressions, Manic,Disorder, Bipolar,Disorder, Bipolar Mood,Disorder, Manic,Manic Depressive Psychosis,Manic Disorders,Mood Disorder, Bipolar,Psychoses, Bipolar Affective,Psychoses, Manic Depressive,Psychosis, Bipolar Affective,Psychosis, Manic Depressive
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Eun-Joo Shin, and Bao-Trong Nguyen, and Ji Hoon Jeong, and Bao-Chau Hoai Nguyen, and Ngoc Kim Cuong Tran, and Naveen Sharma, and Dae-Joong Kim, and Seung-Yeol Nah, and David Lichtstein, and Toshitaka Nabeshima, and Hyoung-Chun Kim
December 2010, Biochimica et biophysica acta,
Eun-Joo Shin, and Bao-Trong Nguyen, and Ji Hoon Jeong, and Bao-Chau Hoai Nguyen, and Ngoc Kim Cuong Tran, and Naveen Sharma, and Dae-Joong Kim, and Seung-Yeol Nah, and David Lichtstein, and Toshitaka Nabeshima, and Hyoung-Chun Kim
November 2014, The Journal of pharmacology and experimental therapeutics,
Eun-Joo Shin, and Bao-Trong Nguyen, and Ji Hoon Jeong, and Bao-Chau Hoai Nguyen, and Ngoc Kim Cuong Tran, and Naveen Sharma, and Dae-Joong Kim, and Seung-Yeol Nah, and David Lichtstein, and Toshitaka Nabeshima, and Hyoung-Chun Kim
January 2019, Evidence-based complementary and alternative medicine : eCAM,
Eun-Joo Shin, and Bao-Trong Nguyen, and Ji Hoon Jeong, and Bao-Chau Hoai Nguyen, and Ngoc Kim Cuong Tran, and Naveen Sharma, and Dae-Joong Kim, and Seung-Yeol Nah, and David Lichtstein, and Toshitaka Nabeshima, and Hyoung-Chun Kim
January 1996, Psychosomatics,
Eun-Joo Shin, and Bao-Trong Nguyen, and Ji Hoon Jeong, and Bao-Chau Hoai Nguyen, and Ngoc Kim Cuong Tran, and Naveen Sharma, and Dae-Joong Kim, and Seung-Yeol Nah, and David Lichtstein, and Toshitaka Nabeshima, and Hyoung-Chun Kim
September 2002, Methods and findings in experimental and clinical pharmacology,
Eun-Joo Shin, and Bao-Trong Nguyen, and Ji Hoon Jeong, and Bao-Chau Hoai Nguyen, and Ngoc Kim Cuong Tran, and Naveen Sharma, and Dae-Joong Kim, and Seung-Yeol Nah, and David Lichtstein, and Toshitaka Nabeshima, and Hyoung-Chun Kim
December 2017, Inflammation research : official journal of the European Histamine Research Society ... [et al.],
Eun-Joo Shin, and Bao-Trong Nguyen, and Ji Hoon Jeong, and Bao-Chau Hoai Nguyen, and Ngoc Kim Cuong Tran, and Naveen Sharma, and Dae-Joong Kim, and Seung-Yeol Nah, and David Lichtstein, and Toshitaka Nabeshima, and Hyoung-Chun Kim
March 2006, American journal of physiology. Regulatory, integrative and comparative physiology,
Eun-Joo Shin, and Bao-Trong Nguyen, and Ji Hoon Jeong, and Bao-Chau Hoai Nguyen, and Ngoc Kim Cuong Tran, and Naveen Sharma, and Dae-Joong Kim, and Seung-Yeol Nah, and David Lichtstein, and Toshitaka Nabeshima, and Hyoung-Chun Kim
May 2010, British journal of pharmacology,
Eun-Joo Shin, and Bao-Trong Nguyen, and Ji Hoon Jeong, and Bao-Chau Hoai Nguyen, and Ngoc Kim Cuong Tran, and Naveen Sharma, and Dae-Joong Kim, and Seung-Yeol Nah, and David Lichtstein, and Toshitaka Nabeshima, and Hyoung-Chun Kim
March 2018, Inflammation research : official journal of the European Histamine Research Society ... [et al.],
Eun-Joo Shin, and Bao-Trong Nguyen, and Ji Hoon Jeong, and Bao-Chau Hoai Nguyen, and Ngoc Kim Cuong Tran, and Naveen Sharma, and Dae-Joong Kim, and Seung-Yeol Nah, and David Lichtstein, and Toshitaka Nabeshima, and Hyoung-Chun Kim
August 1994, Neuroscience letters,
Copied contents to your clipboard!